Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers
Groups of subjects whose primary drug of abuse was amphetamine or heroin were compared, together with age- and IQ-matched control subjects. The study consisted of a neuropsychological test battery which included both conventional tests and also computerised tests of recognition memory, spatial worki...
Gespeichert in:
Veröffentlicht in: | Neuropsychopharmacology (New York, N.Y.) N.Y.), 2000-08, Vol.23 (2), p.113-126 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 126 |
---|---|
container_issue | 2 |
container_start_page | 113 |
container_title | Neuropsychopharmacology (New York, N.Y.) |
container_volume | 23 |
creator | ORNSTEIN, T. J IDDON, J. L BALDACCHINO, A. M SAHAKIAN, B. J LONDON, M EVERITT, B. J ROBBINS, T. W |
description | Groups of subjects whose primary drug of abuse was amphetamine or heroin were compared, together with age- and IQ-matched control subjects. The study consisted of a neuropsychological test battery which included both conventional tests and also computerised tests of recognition memory, spatial working memory, planning, sequence generation, visual discrimination learning, and attentional set-shifting. Many of these tests have previously been shown to be sensitive to cortical damage (including selective lesions of the temporal or frontal lobes) and to cognitive deficits in dementia, basal ganglia disease, and neuropsychiatric disorder. Qualitative differences, as well as some commonalities, were found in the profile of cognitive impairment between the two groups. The chronic amphetamine abusers were significantly impaired in performance on the extra-dimensional shift task (a core component of the Wisconsin Card Sort Test) whereas in contrast, the heroin abusers were impaired in learning the normally easier intra-dimensional shift component. Both groups were impaired in some of tests of spatial working memory. However, the amphetamine group, unlike the heroin group, were not deficient in an index of strategic performance on this test. The heroin group failed to show significant improvement between two blocks of a sequence generation task after training and additionally exhibited more perseverative behavior on this task. The two groups were profoundly, but equivalently impaired on a test of pattern recognition memory sensitive to temporal lobe dysfunction. These results indicate that chronic drug use may lead to distinct patterns of cognitive impairment that may be associated with dysfunction of different components of cortico-striatal circuitry. |
doi_str_mv | 10.1016/S0893-133X(00)00097-X |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_759316783</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>998364051</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-5bd31274fed35a1540ddc7d1c924fd20a7b535234483d9f18124f934ab74cf573</originalsourceid><addsrcrecordid>eNpdkF1rFTEQhkOxtMfan6AsUrC9WJ18bbKXUrQWCwoqnLuQzYcnZTc5JruF_nvTnkOVzs3AzPMOw4PQawzvMeDuww-QPW0xpetzgAsA6EW7PkArLBi0HWXrF2j1hByjl6XcAmAuOnmEjjFISSSVK_T1e04-jK40yTcm_Y5hDneusffFL9HMIcUmxMZscorBNHrabtyspxBdo6NtNi6nutbDUlwur9Ch12Nxp_t-gn59_vTz8kt78-3q-vLjTWtYT-aWD5ZiIph3lnKNOQNrjbDY9IR5S0CLgVNOKGOS2t5jieu8p0wPghnPBT1B73Z3tzn9WVyZ1RSKceOoo0tLUYL3FHdC0kq-fUbepiXH-pwihBNeBfEK8R1kciolO6-2OUw63ysM6sG1enStHkQqAPXoWq1r7s3--DJMzv6X2smtwNke0MXo0WcdTSj_OEZqdfQvvPyGoQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>225250895</pqid></control><display><type>article</type><title>Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>ORNSTEIN, T. J ; IDDON, J. L ; BALDACCHINO, A. M ; SAHAKIAN, B. J ; LONDON, M ; EVERITT, B. J ; ROBBINS, T. W</creator><creatorcontrib>ORNSTEIN, T. J ; IDDON, J. L ; BALDACCHINO, A. M ; SAHAKIAN, B. J ; LONDON, M ; EVERITT, B. J ; ROBBINS, T. W</creatorcontrib><description>Groups of subjects whose primary drug of abuse was amphetamine or heroin were compared, together with age- and IQ-matched control subjects. The study consisted of a neuropsychological test battery which included both conventional tests and also computerised tests of recognition memory, spatial working memory, planning, sequence generation, visual discrimination learning, and attentional set-shifting. Many of these tests have previously been shown to be sensitive to cortical damage (including selective lesions of the temporal or frontal lobes) and to cognitive deficits in dementia, basal ganglia disease, and neuropsychiatric disorder. Qualitative differences, as well as some commonalities, were found in the profile of cognitive impairment between the two groups. The chronic amphetamine abusers were significantly impaired in performance on the extra-dimensional shift task (a core component of the Wisconsin Card Sort Test) whereas in contrast, the heroin abusers were impaired in learning the normally easier intra-dimensional shift component. Both groups were impaired in some of tests of spatial working memory. However, the amphetamine group, unlike the heroin group, were not deficient in an index of strategic performance on this test. The heroin group failed to show significant improvement between two blocks of a sequence generation task after training and additionally exhibited more perseverative behavior on this task. The two groups were profoundly, but equivalently impaired on a test of pattern recognition memory sensitive to temporal lobe dysfunction. These results indicate that chronic drug use may lead to distinct patterns of cognitive impairment that may be associated with dysfunction of different components of cortico-striatal circuitry.</description><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>DOI: 10.1016/S0893-133X(00)00097-X</identifier><identifier>PMID: 10882838</identifier><identifier>CODEN: NEROEW</identifier><language>eng</language><publisher>New York, NY: Nature Publishing</publisher><subject>Adolescent ; Adult ; Amphetamine-Related Disorders - complications ; Amphetamine-Related Disorders - physiopathology ; Amphetamines - adverse effects ; Analysis of Variance ; Attention - drug effects ; Biological and medical sciences ; Chronic Disease ; Cognition Disorders - diagnosis ; Cognition Disorders - etiology ; Drug addictions ; Female ; Heroin - adverse effects ; Heroin Dependence - complications ; Heroin Dependence - physiopathology ; Humans ; Language Tests ; Male ; Medical sciences ; Memory - drug effects ; Middle Aged ; Neuropsychological Tests ; Pattern Recognition, Visual - drug effects ; Reaction Time - drug effects ; Set, Psychology ; Toxicology</subject><ispartof>Neuropsychopharmacology (New York, N.Y.), 2000-08, Vol.23 (2), p.113-126</ispartof><rights>2000 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Aug 2000</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-5bd31274fed35a1540ddc7d1c924fd20a7b535234483d9f18124f934ab74cf573</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1422226$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10882838$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ORNSTEIN, T. J</creatorcontrib><creatorcontrib>IDDON, J. L</creatorcontrib><creatorcontrib>BALDACCHINO, A. M</creatorcontrib><creatorcontrib>SAHAKIAN, B. J</creatorcontrib><creatorcontrib>LONDON, M</creatorcontrib><creatorcontrib>EVERITT, B. J</creatorcontrib><creatorcontrib>ROBBINS, T. W</creatorcontrib><title>Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers</title><title>Neuropsychopharmacology (New York, N.Y.)</title><addtitle>Neuropsychopharmacology</addtitle><description>Groups of subjects whose primary drug of abuse was amphetamine or heroin were compared, together with age- and IQ-matched control subjects. The study consisted of a neuropsychological test battery which included both conventional tests and also computerised tests of recognition memory, spatial working memory, planning, sequence generation, visual discrimination learning, and attentional set-shifting. Many of these tests have previously been shown to be sensitive to cortical damage (including selective lesions of the temporal or frontal lobes) and to cognitive deficits in dementia, basal ganglia disease, and neuropsychiatric disorder. Qualitative differences, as well as some commonalities, were found in the profile of cognitive impairment between the two groups. The chronic amphetamine abusers were significantly impaired in performance on the extra-dimensional shift task (a core component of the Wisconsin Card Sort Test) whereas in contrast, the heroin abusers were impaired in learning the normally easier intra-dimensional shift component. Both groups were impaired in some of tests of spatial working memory. However, the amphetamine group, unlike the heroin group, were not deficient in an index of strategic performance on this test. The heroin group failed to show significant improvement between two blocks of a sequence generation task after training and additionally exhibited more perseverative behavior on this task. The two groups were profoundly, but equivalently impaired on a test of pattern recognition memory sensitive to temporal lobe dysfunction. These results indicate that chronic drug use may lead to distinct patterns of cognitive impairment that may be associated with dysfunction of different components of cortico-striatal circuitry.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Amphetamine-Related Disorders - complications</subject><subject>Amphetamine-Related Disorders - physiopathology</subject><subject>Amphetamines - adverse effects</subject><subject>Analysis of Variance</subject><subject>Attention - drug effects</subject><subject>Biological and medical sciences</subject><subject>Chronic Disease</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cognition Disorders - etiology</subject><subject>Drug addictions</subject><subject>Female</subject><subject>Heroin - adverse effects</subject><subject>Heroin Dependence - complications</subject><subject>Heroin Dependence - physiopathology</subject><subject>Humans</subject><subject>Language Tests</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory - drug effects</subject><subject>Middle Aged</subject><subject>Neuropsychological Tests</subject><subject>Pattern Recognition, Visual - drug effects</subject><subject>Reaction Time - drug effects</subject><subject>Set, Psychology</subject><subject>Toxicology</subject><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkF1rFTEQhkOxtMfan6AsUrC9WJ18bbKXUrQWCwoqnLuQzYcnZTc5JruF_nvTnkOVzs3AzPMOw4PQawzvMeDuww-QPW0xpetzgAsA6EW7PkArLBi0HWXrF2j1hByjl6XcAmAuOnmEjjFISSSVK_T1e04-jK40yTcm_Y5hDneusffFL9HMIcUmxMZscorBNHrabtyspxBdo6NtNi6nutbDUlwur9Ch12Nxp_t-gn59_vTz8kt78-3q-vLjTWtYT-aWD5ZiIph3lnKNOQNrjbDY9IR5S0CLgVNOKGOS2t5jieu8p0wPghnPBT1B73Z3tzn9WVyZ1RSKceOoo0tLUYL3FHdC0kq-fUbepiXH-pwihBNeBfEK8R1kciolO6-2OUw63ysM6sG1enStHkQqAPXoWq1r7s3--DJMzv6X2smtwNke0MXo0WcdTSj_OEZqdfQvvPyGoQ</recordid><startdate>20000801</startdate><enddate>20000801</enddate><creator>ORNSTEIN, T. J</creator><creator>IDDON, J. L</creator><creator>BALDACCHINO, A. M</creator><creator>SAHAKIAN, B. J</creator><creator>LONDON, M</creator><creator>EVERITT, B. J</creator><creator>ROBBINS, T. W</creator><general>Nature Publishing</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20000801</creationdate><title>Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers</title><author>ORNSTEIN, T. J ; IDDON, J. L ; BALDACCHINO, A. M ; SAHAKIAN, B. J ; LONDON, M ; EVERITT, B. J ; ROBBINS, T. W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-5bd31274fed35a1540ddc7d1c924fd20a7b535234483d9f18124f934ab74cf573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Amphetamine-Related Disorders - complications</topic><topic>Amphetamine-Related Disorders - physiopathology</topic><topic>Amphetamines - adverse effects</topic><topic>Analysis of Variance</topic><topic>Attention - drug effects</topic><topic>Biological and medical sciences</topic><topic>Chronic Disease</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cognition Disorders - etiology</topic><topic>Drug addictions</topic><topic>Female</topic><topic>Heroin - adverse effects</topic><topic>Heroin Dependence - complications</topic><topic>Heroin Dependence - physiopathology</topic><topic>Humans</topic><topic>Language Tests</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory - drug effects</topic><topic>Middle Aged</topic><topic>Neuropsychological Tests</topic><topic>Pattern Recognition, Visual - drug effects</topic><topic>Reaction Time - drug effects</topic><topic>Set, Psychology</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ORNSTEIN, T. J</creatorcontrib><creatorcontrib>IDDON, J. L</creatorcontrib><creatorcontrib>BALDACCHINO, A. M</creatorcontrib><creatorcontrib>SAHAKIAN, B. J</creatorcontrib><creatorcontrib>LONDON, M</creatorcontrib><creatorcontrib>EVERITT, B. J</creatorcontrib><creatorcontrib>ROBBINS, T. W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ORNSTEIN, T. J</au><au>IDDON, J. L</au><au>BALDACCHINO, A. M</au><au>SAHAKIAN, B. J</au><au>LONDON, M</au><au>EVERITT, B. J</au><au>ROBBINS, T. W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><addtitle>Neuropsychopharmacology</addtitle><date>2000-08-01</date><risdate>2000</risdate><volume>23</volume><issue>2</issue><spage>113</spage><epage>126</epage><pages>113-126</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><coden>NEROEW</coden><abstract>Groups of subjects whose primary drug of abuse was amphetamine or heroin were compared, together with age- and IQ-matched control subjects. The study consisted of a neuropsychological test battery which included both conventional tests and also computerised tests of recognition memory, spatial working memory, planning, sequence generation, visual discrimination learning, and attentional set-shifting. Many of these tests have previously been shown to be sensitive to cortical damage (including selective lesions of the temporal or frontal lobes) and to cognitive deficits in dementia, basal ganglia disease, and neuropsychiatric disorder. Qualitative differences, as well as some commonalities, were found in the profile of cognitive impairment between the two groups. The chronic amphetamine abusers were significantly impaired in performance on the extra-dimensional shift task (a core component of the Wisconsin Card Sort Test) whereas in contrast, the heroin abusers were impaired in learning the normally easier intra-dimensional shift component. Both groups were impaired in some of tests of spatial working memory. However, the amphetamine group, unlike the heroin group, were not deficient in an index of strategic performance on this test. The heroin group failed to show significant improvement between two blocks of a sequence generation task after training and additionally exhibited more perseverative behavior on this task. The two groups were profoundly, but equivalently impaired on a test of pattern recognition memory sensitive to temporal lobe dysfunction. These results indicate that chronic drug use may lead to distinct patterns of cognitive impairment that may be associated with dysfunction of different components of cortico-striatal circuitry.</abstract><cop>New York, NY</cop><pub>Nature Publishing</pub><pmid>10882838</pmid><doi>10.1016/S0893-133X(00)00097-X</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0893-133X |
ispartof | Neuropsychopharmacology (New York, N.Y.), 2000-08, Vol.23 (2), p.113-126 |
issn | 0893-133X 1740-634X |
language | eng |
recordid | cdi_proquest_miscellaneous_759316783 |
source | MEDLINE; Springer Nature - Complete Springer Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Adolescent Adult Amphetamine-Related Disorders - complications Amphetamine-Related Disorders - physiopathology Amphetamines - adverse effects Analysis of Variance Attention - drug effects Biological and medical sciences Chronic Disease Cognition Disorders - diagnosis Cognition Disorders - etiology Drug addictions Female Heroin - adverse effects Heroin Dependence - complications Heroin Dependence - physiopathology Humans Language Tests Male Medical sciences Memory - drug effects Middle Aged Neuropsychological Tests Pattern Recognition, Visual - drug effects Reaction Time - drug effects Set, Psychology Toxicology |
title | Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T03%3A19%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Profiles%20of%20cognitive%20dysfunction%20in%20chronic%20amphetamine%20and%20heroin%20abusers&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=ORNSTEIN,%20T.%20J&rft.date=2000-08-01&rft.volume=23&rft.issue=2&rft.spage=113&rft.epage=126&rft.pages=113-126&rft.issn=0893-133X&rft.eissn=1740-634X&rft.coden=NEROEW&rft_id=info:doi/10.1016/S0893-133X(00)00097-X&rft_dat=%3Cproquest_cross%3E998364051%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=225250895&rft_id=info:pmid/10882838&rfr_iscdi=true |